Supported by

Supported by

Topics (Newest)

- Topics (Newest)
- IND Requirements for COVID-19
  Started by J WC in: Regulatory Considerations
- 1
  1
- Combination treatment for COVID-19
  Started by J WC in: Therapeutics for COVID-19
- 1
  1
- Repurposing drugs for COVID-19
  Started by J WC in: Therapeutics for COVID-19
- 1
  1
- Ivermectin
  Started by J WC in: Therapeutics for COVID-19
- 1
  1
- EMA provides recommendations on compassionate use of remdesivir
  Started by J WC in: Regulatory Considerations
- 1
  1
- FDA launches Coronavirus Treatment Acceleration Program (CTAP)
  Started by J WC in: Regulatory Considerations
- 1
  1
- Tocilizumab or atlizumab
  Started by J WC in: Therapeutics for COVID-19
- 1
  1
- Pregnant Women
  Started by J WC in: Dosing for Special Patient Populations
- 1
  1
- Elderly Patients
  Started by J WC in: Dosing for Special Patient Populations
- 1
  1
- ICU and Critical Care Patients
  Started by J WC in: Dosing for Special Patient Populations
- 1
  1
- Men vs Women
  Started by J WC in: Dosing for Special Patient Populations
- 1
  1
- Remdesivir
  Started by COVID-19 Pharmacology in: Therapeutics for COVID-19
- 1
  2
- Introduction to In Silico Workbench
  Started by J WC in: In Silico Workbench
- 1
  1
- BNT162
  Started by J WC in: Vaccines for COVID-19
- 1
  1
- Lopinavir/ritonavir
  Started by COVID-19 Pharmacology in: Therapeutics for COVID-19
- 1
  1

← 1 2 3 4 →